Related Experiment Video
Updated: Dec 23, 2025

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Enhancing the Cellular Uptake and Antibacterial Activity of Rifampicin through Encapsulation in Mesoporous Silica
Paul Joyce1, Hanna Ulmefors2,3, Sajedeh Maghrebi2,3
1Department of Physics, Chalmers University of Technology, SE-412 96 Gothenburg, Sweden.
Abstract:
An urgent demand exists for the development of novel delivery systems that efficiently transport antibacterial agents across cellular membranes for the eradication of intracellular pathogens. In this study, the clinically relevant poorly water-soluble antibiotic, rifampicin, was confined within mesoporous silica nanoparticles (MSN) to investigate their ability to serve as an efficacious nanocarrier system against small colony variants of Staphylococcus aureus (SCV S. aureus) hosted within Caco-2 cells. The surface chemistry and particle size of MSN were varied through modifications during synthesis, where 40 nm particles with high silanol group densities promoted enhanced cellular uptake. Extensive biophysical analysis was performed, using quartz crystal microbalance with dissipation (QCM-D) and total internal reflection fluorescence (TIRF) microscopy, to elucidate the mechanism of MSN adsorption onto semi-native supported lipid bilayers (snSLB) and, thus, uncover potential cellular uptake mechanisms of MSN into Caco-2 cells. Such studies revealed that MSN with reduced silanol group densities were prone to greater particle aggregation on snSLB, which was expected to restrict endocytosis. MSN adsorption and uptake into Caco-2 cells correlated well with antibacterial efficacy against SCV S. aureus, with 40 nm hydrophilic particles triggering a ~2.5-log greater reduction in colony forming units, compared to the pure rifampicin. Thus, this study provides evidence for the potential to design silica nanocarrier systems with controlled surface chemistries that can be used to re-sensitise intracellular bacteria to antibiotics by delivering them to the site of infection.
Insights
Mesoporous silica nanoparticles (MSN) effectively delivered the antibiotic rifampicin into cells, significantly improving eradication of intracellular Staphylococcus aureus. Optimized MSN properties enhanced cellular uptake and antibacterial efficacy.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Infectious Diseases
Background:
- Intracellular bacterial infections require novel drug delivery systems.
- Rifampicin is a key antibiotic but faces challenges with intracellular pathogens.
- Small colony variants (SCV) of Staphylococcus aureus are difficult to treat.
Purpose of the Study:
- To develop mesoporous silica nanoparticles (MSN) as a delivery system for rifampicin.
- To investigate MSN's efficacy against intracellular SCV S. aureus in Caco-2 cells.
- To understand the relationship between MSN properties, cellular uptake, and antibacterial activity.
Main Methods:
- Synthesized MSN with varied surface chemistry and particle size (e.g., 40 nm).
- Utilized quartz crystal microbalance with dissipation (QCM-D) and TIRF microscopy for biophysical analysis.
- Assessed antibacterial efficacy against SCV S. aureus in Caco-2 cell models.
Main Results:
- 40 nm MSN with high silanol group density enhanced cellular uptake.
- MSN adsorption and uptake correlated with improved antibacterial action.
- Hydrophilic 40 nm MSN achieved a ~2.5-log greater reduction in CFUs compared to free rifampicin.
Conclusions:
- Tailored MSN can serve as effective nanocarriers for intracellular antibiotic delivery.
- Optimizing MSN surface chemistry and size is crucial for enhanced cellular uptake and efficacy.
- This approach shows potential for re-sensitizing intracellular bacteria to antibiotics.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement

